Skip to main content

Stable Ischemic Heart Disease Beyond Stenoses: Coronary Microvascular Dysfunction

  • Chapter
  • First Online:
Manual of Gynecardiology

Abstract

At least half of (predominant) female patients with recurrent angina, without signs of obstructive CAD, have underlying coronary microvascular dysfunction (CMD). Especially when signs of ischemia are present, this syndrome has an adverse prognosis. Patients with CMD have a characteristic symptom presentation, with a variety of traditional and non-traditional risk factors. Diagnostic testing and treatment are still a challenge, with much room for improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Shaw LJ, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47(3 Suppl):S4–S20.

    Article  PubMed  Google Scholar 

  2. Bairey Merz CN, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21–9.

    Article  PubMed  Google Scholar 

  3. Patel MB, et al. Imaging microvascular dysfunction and mechanisms for female-male differences in CAD. JACC Cardiovasc Imaging. 2016;9(4):465–82.

    Article  PubMed  Google Scholar 

  4. Jespersen L, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734–44.

    Article  PubMed  Google Scholar 

  5. Johnston N, Schenck-Gustafsson K, Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur Heart J. 2011;32(11):1331–6.

    Article  PubMed  Google Scholar 

  6. Pepine CJ. Multiple causes for ischemia without obstructive coronary artery disease: not a short list. Circulation. 2015;131(12):1044–6.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Pepine CJ, et al. Emergence of nonobstructive coronary artery disease: a woman’s problem and need for change in definition on angiography. J Am Coll Cardiol. 2015;66(17):1918–33.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Khuddus MA, et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). J Interv Cardiol. 2010;23(6):511–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lee BK, et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015;131(12):1054–60.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Marinescu MA, et al. Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imaging. 2015;8(2):210–20.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lin FY, et al. Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography. J Am Coll Cardiol. 2011;58(5):510–9.

    Article  PubMed  Google Scholar 

  12. Maddox TM, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312(17):1754–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Murthy VL, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129(24):2518–27.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Johnson BD, et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J. 2006;27(12):1408–15.

    Article  PubMed  Google Scholar 

  15. Gulati M, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169(9):843–50.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J. 2012;33(22):2771–2782b.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Camici PG, d’Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol. 2015;12(1):48–62.

    Article  PubMed  Google Scholar 

  18. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830–40.

    Article  CAS  PubMed  Google Scholar 

  19. Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121(21):2317–25.

    Article  PubMed  Google Scholar 

  20. Task Force M, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.

    Article  Google Scholar 

  21. Ong P, et al. Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol. 2012;101(8):673–81.

    Article  CAS  PubMed  Google Scholar 

  22. Cosin-Sales J, et al. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol. 2003;41(9):1468–74.

    Article  CAS  PubMed  Google Scholar 

  23. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35(17):1101–11.

    Article  PubMed  Google Scholar 

  24. Wessel TR, et al. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE). Clin Cardiol. 2007;30(2):69–74.

    Article  PubMed  Google Scholar 

  25. Gianturco L, et al. Cardiovascular and autoimmune diseases in females: the role of microvasculature and dysfunctional endothelium. Atherosclerosis. 2015;241(1):259–63.

    Article  CAS  PubMed  Google Scholar 

  26. Faccini A, Kaski JC, Camici PG. Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases. Eur Heart J. 2016;37(23):1799–806.

    Article  PubMed  Google Scholar 

  27. Rodes-Cabau J, et al. Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis in the proximal-mid segment of a coronary artery by myocardial fractional flow reserve measurements. Am J Cardiol. 2011;108(4):483–90.

    Article  PubMed  Google Scholar 

  28. Panza JA, et al. Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol. 1997;29(2):293–301.

    Article  CAS  PubMed  Google Scholar 

  29. Wei J, et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv. 2012;5(6):646–53.

    Article  PubMed  PubMed Central  Google Scholar 

  30. von Mering GO, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109(6):722–5.

    Article  Google Scholar 

  31. Pepine CJ, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55(25):2825–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ong P, et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation. 2014;129(17):1723–30.

    Article  CAS  PubMed  Google Scholar 

  33. Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, Shimokawa H, Bairey Merz CN; Coronary Vasomotion Disorders International Study Group (COVADIS).International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2015;4. pii:ehv351. [Epub ahead of print] Review.

    Google Scholar 

  34. Meimoun P, Tribouilloy C. Non-invasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography: a magic tool for the real world. Eur J Echocardiogr. 2008;9(4):449–57.

    Article  PubMed  Google Scholar 

  35. Lanza GA, et al. Methods to investigate coronary microvascular function in clinical practice. J Cardiovasc Med (Hagerstown). 2013;14(1):1–18.

    Article  Google Scholar 

  36. Schindler TH, et al. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging. 2010;3(6):623–40.

    Article  PubMed  Google Scholar 

  37. Ong P, Athanasiadis A, Sechtem U. Treatment of angina pectoris associated with coronary microvascular dysfunction. Cardiovasc Drugs Ther. 2016;30(4):351–6.

    Article  CAS  PubMed  Google Scholar 

  38. Sen N, et al. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. Anadolu Kardiyol Derg. 2009;9(5):371–9.

    PubMed  Google Scholar 

  39. Lamendola P, et al. Long-term prognosis of patients with cardiac syndrome X. Int J Cardiol. 2010;140(2):197–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suzette Elias-Smale M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Elias-Smale, S. (2017). Stable Ischemic Heart Disease Beyond Stenoses: Coronary Microvascular Dysfunction. In: Maas, A., Bairey Merz, C. (eds) Manual of Gynecardiology. Springer, Cham. https://doi.org/10.1007/978-3-319-54960-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54960-6_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54959-0

  • Online ISBN: 978-3-319-54960-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics